Listar por autor "González, A."
Mostrando ítems 1-2 de 2
-
Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array. Pérez-Gracia, J. L.; Prior, C.; Guillén-Grima, F.; Segura, V.; González, A.; Panizo, A.; Melero, I.; Grande-Pulido, E.; Gurpide, A.; Gurpide, A.; Gil-Bazo, I.; Calvo, A. (British Journal of Cancer, 2009)
-
Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes. Alfaro, C.; Suárez, N.; González, A.; Solano, S.; Erro, L.; Dubrot, J.; Palazón, A.; Hervas-Stubbs, S.; Gurpide, A.; López-Picazo, J.M.; Grande-Pulido, E.; Melero, I.; Pérez-Gracia, J. L. (British Journal of Cancer, 2009)